Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload

Nan Zhang; Hai-Han Liao; Hong Feng; Shan-Qi Mou; Wen-Jing Li; Xiahenazi Aiyasiding; Zheng Lin; Wen Ding; Zi-Ying Zhou; Han Yan; Si Chen; Qi-Zhu Tang

doi:10.3389/fphar.2021.716884

Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload

Front Pharmacol. 2021 Nov 17:12:716884. doi: 10.3389/fphar.2021.716884. eCollection 2021.

Authors

Nan Zhang^{1

2

3}, Hai-Han Liao^{1

2

3}, Hong Feng⁴, Shan-Qi Mou^{1

2

3}, Wen-Jing Li^{1

2

3}, Xiahenazi Aiyasiding^{1

2

3}, Zheng Lin^{1

2

3}, Wen Ding^{1

2

3}, Zi-Ying Zhou^{1

2

3}, Han Yan², Si Chen^{2

3}, Qi-Zhu Tang^{1

2

3}

Affiliations

¹ Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
² Cardiovascular Research Institute of Wuhan University, Wuhan, China.
³ Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, China.
⁴ Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China.

Abstract

Objectives: Sestrin2 (Sesn2) has been demonstrated to be a cysteine sulfinyl reductase and protects cells from multiple stress insults, including hypoxia, endoplasmic reticulum stress, and oxidative stress. However, the roles and mechanisms of Sesn2 in pressure overload-induced mouse cardiac hypertrophy have not been clearly clarified. This study intended to investigate whether sestrin2 (Sesn2) overexpression could prevent pressure overload-induced cardiac hypertrophy via an AMPKα2 dependent pathway through conditional knockout of AMPKα2. Methods and results: Sesn2 expression was significantly increased in mice hearts at 2 and 4 weeks after aortic banding (AB) surgery, but decreased to 60-70% of the baseline at 8 weeks. Sesn2 overexpression (at 3, 6, and 9 folds) showed little cardiac genetic toxicity in transgenic mice. Cardiac dysfunctions induced by pressure overload were attenuated by cardiomyocyte-specific Sesn2 overexpression when measured by echocardiography and hemodynamic analysis. Results of HE and PSR staining showed that Sesn2 overexpression significantly alleviated cardiac hypertrophy and fibrosis in mice hearts induced by pressure overload. Meanwhile, adenovirus-mediated-Sesn2 overexpression markedly suppressed angiotensin II-induced neonatal rat cardiomyocyte hypertrophy in vitro. Mechanistically, Sesn2 overexpression increased AMPKα2 phosphorylation but inhibited mTORC1 phosphorylation. The cardiac protections of Sesn2 overexpression were also via regulating oxidative stress by enhancing Nrf2/HO-1 signaling, restoring SOD activity, and suppressing NADPH activity. Particularly, we first proved the vital role of AMPKα2 in the regulation of Sesn2 with AMPKα2 knockout (AMPKα2-/-) mice and Sesn2 transgenic mice crossed with AMPKα2-/-, since Sesn2 overexpression failed to improve cardiac function, inhibit cardiac hypertrophy and fibrosis, and attenuate oxidative stress after AMPKα2 knockout. Conclusion: This study uniquely revealed that Sesn2 overexpression showed little genetic toxicity in mice hearts and inhibited mTORC1 activation and oxidative stress to protect against pressure overload-induced cardiac hypertrophy in an AMPKα2 dependent pathway. Thus, interventions through promoting Sesn2 expression might be a potential strategy for treating pathological cardiac hypertrophy and heart failure.

Keywords: AMPKα; Sestrin2; cardiac hypertrophy; fibrosis; oxidative stress.